Michael H Skinner

Summary

Affiliation: Eli Lilly and Company
Country: USA

Publications

  1. ncbi Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers
    Michael H Skinner
    Lilly Laboratory for Clinical Research, Indiana University Hospital and Outpatient Center, 550 N University Road, Indianapolis, IN 46202 5250, USA
    Clin Pharmacol Ther 73:170-7. 2003
  2. pmc Effect of age on the pharmacokinetics of duloxetine in women
    Michael H Skinner
    Lilly Laboratory for Clinical Research, Indiana University Hospital and Outpatient Center, Indianapolis, IN 46202, USA
    Br J Clin Pharmacol 57:54-61. 2004
  3. pmc Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers
    Teng C Hua
    Lilly NUS Centre for Clinical Pharmacology, National University of Singapore, Singapore
    Br J Clin Pharmacol 57:652-6. 2004

Collaborators

Detail Information

Publications3

  1. ncbi Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers
    Michael H Skinner
    Lilly Laboratory for Clinical Research, Indiana University Hospital and Outpatient Center, 550 N University Road, Indianapolis, IN 46202 5250, USA
    Clin Pharmacol Ther 73:170-7. 2003
    ....
  2. pmc Effect of age on the pharmacokinetics of duloxetine in women
    Michael H Skinner
    Lilly Laboratory for Clinical Research, Indiana University Hospital and Outpatient Center, Indianapolis, IN 46202, USA
    Br J Clin Pharmacol 57:54-61. 2004
    ..The effect of age on duloxetine pharmacokinetics was evaluated in healthy volunteers and in patients with urinary incontinence...
  3. pmc Effect of duloxetine on tolterodine pharmacokinetics in healthy volunteers
    Teng C Hua
    Lilly NUS Centre for Clinical Pharmacology, National University of Singapore, Singapore
    Br J Clin Pharmacol 57:652-6. 2004
    ..To investigate the effect of duloxetine on the pharmacokinetics and tolerability of tolterodine and its active 5-hydroxymethyl metabolite (5-HM)...